Taxotere Aventis Pharmaceuticals Inc. - Treatment for Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Gastric Cancer
Taxotere is a taxoid antineoplastic agent indicated for the treatment of patients with certain types of breast cancer, locally advanced or metastatic non-small cell lung cancer, androgen independent metastatic prostate cancer and advanced gastric adenocarcinoma.Posted: May 1996
Related articles
- FDA Approves New Taxotere (docetaxel) Injection Concentrate Formulation - August 5, 2010
- Taxotere (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery - October 1, 2007
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
